Bare lymphocyte syndrome type II

Bare lymphocyte syndrome type II (BLS II) is a rare recessive genetic condition in which a group of genes called major histocompatibility complex class II (MHC class II) are not expressed.[3][4] The result is that the immune system is severely compromised and cannot effectively fight infection.

Bare lymphocyte syndrome type II
Other namesHLA class 2-negative severe combined immunodeficiency, HLA Class 2-Negative
Bare lymphocyte syndrome 2 is autosomal recessive in inheritance
CausesAbsence of human leukocyte antigen class II expression [1]
Diagnostic methodGenetic test[1]
MedicationBone marrow transplant[2]

Symptoms and signs

Among the signs and symptoms that Bare lymphocyte syndrome type II exhibits are the following:[1][5]

Cause

The genetic cause of Bare lymphocyte syndrome type II is due to mutations in any of the following genes:[5]

  • CIITA is responsible for giving instructions to create a protein that controls transcription of genes (MHC class II), and is located at 16p13.13 (cytogenetic location),[6]
  • RFX5 has the same function(as prior gene) and is located at 1q21.3(cytogenetic location)[7]
  • RFXANK(also known as ankyrin repeat-containing regulatory factor X-associated protein) has the same function(as the other genes) and is located at 19p13.11(cytogenetic location)[8]
  • RFXAP gives information to create RFX associated protein, which also is involved in transcription of MHC class II genes, and is located at 13q13.3,(cytogenetic location)[9]

Mechanism
MHC Class 2

Major histocompatibility complex class II proteins are important because under normal function they have important responsibility in the human body's immune system response, CD4+(CD8+) T-lymphocytes, receive peptide antigens from them[10]

The basis for BLSII is not due to defects in the MHC II genes themselves, it is the result of mutations in genes that code for proteins, transcription factors that normally regulate the expression of the MHC II genes. One of the several proteins that are required to switch on MHC II genes in various cells types is absent.[5]

Diagnosis

The diagnosis for Bare lymphocyte syndrome type II can be done via genetic testing[11] A blood test could indicate decreased CD4+ T-cells(T-helper lymphocyte), as well as serum immunoglobulin[2]

Management
Bone marrow

In terms of treatment for major histocompatibility complex class II deficiency(Bare lymphocyte syndrome type II), one finds that according to Matheux, et al. a possible treatment for this condition might be found in cellular and gene therapy[12] The prognosis is poor (without treatment) in early childhood for this condition;[13][2] additional treatment options include anti-microbial prophylaxis prior to bone marrow transplant[2][14]

See also

References
  1. "Bare lymphocyte syndrome 2 | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2017-07-28.
  2. al.], Stephan Strobel ... [et; Smith, Peter K. (2006). Paediatrics and Child Health the Great Ormond Street Handbook. London: Manson Pub. p. 465. ISBN 9781840765625. Retrieved 28 July 2017.
  3. "OMIM Entry - # 209920 - BARE LYMPHOCYTE SYNDROME, TYPE II". omim.org. Retrieved 2017-07-13.
  4. Reference, Genetics Home. "bare lymphocyte syndrome type II". Genetics Home Reference. Retrieved 2017-07-13.
  5. "SCID due to absent class II HLA antigens (Concept Id: C0242583) - MedGen - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-07-28.
  6. Reference, Genetics Home. "CIITA gene". Genetics Home Reference. Retrieved 2017-07-28.
  7. Reference, Genetics Home. "RFX5 gene". Genetics Home Reference. Retrieved 2017-07-28.
  8. Reference, Genetics Home. "RFXANK gene". Genetics Home Reference. Retrieved 2017-07-28.
  9. Reference, Genetics Home. "RFXAP gene". Genetics Home Reference. Retrieved 2017-07-28.
  10. Holling, Tjadine M.; Schooten, Erik; van Den Elsen, Peter J. (April 2004). "Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men". Human Immunology. 65 (4): 282–290. doi:10.1016/j.humimm.2004.01.005. ISSN 0198-8859. PMID 15120183. – via ScienceDirect (Subscription may be required or content may be available in libraries.)
  11. "Bare lymphocyte syndrome type 2, complementation group A - Conditions - GTR - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-07-28.
  12. Matheux, Franck; Villard, Jean (June 2004). "Cellular and gene therapy for major histocompatibility complex class II deficiency". News in Physiological Sciences. 19: 154–158. ISSN 0886-1714. PMID 15143213.
  13. RESERVED, INSERM US14 -- ALL RIGHTS. "Orphanet: Immunodeficiency by defective expression of HLA class 2". www.orpha.net. Retrieved 2017-07-28.
  14. Bratzler, Dale W.; Dellinger, E. Patchen; Olsen, Keith M.; Perl, Trish M.; Auwaerter, Paul G.; Bolon, Maureen K.; Fish, Douglas N.; Napolitano, Lena M.; Sawyer, Robert G. (February 2013). "Clinical practice guidelines for antimicrobial prophylaxis in surgery" (PDF). Surgical Infections. 14 (1): 73–156. doi:10.1089/sur.2013.9999. hdl:2027.42/140217. ISSN 1557-8674. PMID 23461695.subscription needed

Further reading
Classification
External resources
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.